{"id":903,"date":"2024-12-03T18:08:12","date_gmt":"2024-12-03T18:08:12","guid":{"rendered":"https:\/\/naujienosversle.lt\/index.php\/2024\/12\/03\/kembridze-isikurusi-52north-uzsitikrina-57-mln\/"},"modified":"2024-12-03T18:08:12","modified_gmt":"2024-12-03T18:08:12","slug":"kembridze-isikurusi-52north-uzsitikrina-57-mln","status":"publish","type":"post","link":"https:\/\/naujienosversle.lt\/index.php\/2024\/12\/03\/kembridze-isikurusi-52north-uzsitikrina-57-mln\/","title":{"rendered":"Kembrid\u017ee \u012fsik\u016brusi 52North u\u017esitikrina 5,7 mln."},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>52North, JK medicinos technologij\u0173 startuolis, orientuotas \u012f onkologini\u0173 lig\u0173 pa\u017eang\u0105, surinko 6 mln. EUR per finansavim\u0105, kuriam kartu vadovavo KHP Ventures ir Cedars-Sinai Intellectual Property Co. (CSIP).<\/p>\n<p>Turas, \u012f kur\u012f taip pat \u012fne\u0161\u0117 \u201eOKG Capital\u201c, \u201eCambridge Enterprise Ventures\u201c, \u201eCancer Research Horizons\u201c, \u201eMacmillan Cancer Support\u201c ir investuotojai angelai, tokie kaip Jonathanas Milneris ir Rolandas Diggelmannas, padidino bendr\u0105 bendrov\u0117s finansavim\u0105 iki 9,5 mln. Turas taip pat gavo naudos i\u0161 Nacionalinio sveikatos ir prie\u017ei\u016bros tyrim\u0173 instituto (NIHR) suteiktos 1,4 mln.<\/p>\n<p>52North teigimu, \u0161is finansavimas yra pirmas kartas, kai pirmaujantys ligonini\u0173 rizikos fondai i\u0161 JK ir JAV kartu vadovauja investicijoms.<\/p>\n<p>Umaima Ahmad, \u201e52North\u201c generalin\u0117 direktor\u0117, pabr\u0117\u017e\u0117 \u0161io finansavimo etapo svarb\u0105: \u201e<em>\u0160is raundas rei\u0161kia didel\u012f 52North \u0161uol\u012f \u012f priek\u012f. Palaikydami tiek JK, tiek JAV sveikatos prie\u017ei\u016bros lyderius, galime i\u0161pl\u0117sti savo produkt\u0173 asortiment\u0105 bendradarbiaudami su pagrindiniais strateginiais partneriais ir tinkamai panaudoti naujausius \u012frankius, \u012fskaitant dirbtin\u012f intelekt\u0105, kad pakeistume skubios pacient\u0173 prie\u017ei\u016bros b\u016bdus visame pasaulyje. KHP Ventures ir Cedars Sinai \u012fsipareigojimai rodo tik\u0117jim\u0105 m\u016bs\u0173 vizija ir sprendim\u0173 verte.<\/em>\u201c<\/p>\n<p>Startuolio pasi\u016blos pagrindas yra Neutrocheck\u00ae \u2013 prie\u017ei\u016bros ta\u0161kas ir program\u0117l\u0117, skirta steb\u0117ti pacientams, kuriems taikoma chemoterapija, d\u0117l neutropenijos ar neutropeninio sepsio \u2013 komplikacij\u0173, kurios gali kelti pavoj\u0173 gyvybei \u2013 rizika.<\/p>\n<p>\u0160io etapo l\u0117\u0161os paskatins 52North pastangas pristatyti Neutrocheck\u00ae \u012f rink\u0105, i\u0161pl\u0117sti savo produkt\u0173 tiekim\u0105 ir sustiprinti bendrov\u0117s Aster\u2122 platform\u0105. \u0160ia platforma siekiama pateikti ekonomi\u0161kus nuotolinio l\u0105steli\u0173 steb\u0117jimo sprendimus ir sustiprinti bendradarbiavim\u0105 su farmacijos partneriais. Be to, l\u0117\u0161omis remiamas ACORN\u2122 \u2013 dirbtiniu intelektu pagr\u012fstos platformos, sukurtos su NIHR parama, diegimas siekiant padidinti \u016bmin\u0117s onkologin\u0117s prie\u017ei\u016bros teikimo saugum\u0105.<\/p>\n<p>Timas Irishas, \u200b\u200bKHP Ventures pirmininkas, pa\u017eym\u0117jo:<em>M\u016bs\u0173 partneryst\u0117 su Cedars-Sinai atspindi m\u016bs\u0173 bendr\u0105 misij\u0105 investuoti ir remti \u012fmones, kurios gali pakeisti sveikatos prie\u017ei\u016bros paslaug\u0173 teikim\u0105 pasauliniu mastu. Did\u017eiuojam\u0117s gal\u0117dami toliau palaikyti 52North, nes jie ir toliau kuria sprendimus, suteikian\u010dius gali\u0173 tiek pacientams, tiek gydytojams.<\/em>\u201c<\/p>\n<p>Dar labiau pabr\u0117\u017edamas bendradarbiavimo vizij\u0105, Nirdesh Gupta, CSIP vadovaujantis partneris, prid\u016br\u0117:<em>\u201eCedars-Sinai\u201c yra skirta pa\u017eangioms technologijoms, kurios pagerina pacient\u0173 prie\u017ei\u016br\u0105 ir skatina transformuojan\u010dius sveikatos prie\u017ei\u016bros sprendimus. 52North \u012fsipareigojimas diegti naujoves onkologin\u0117s prie\u017ei\u016bros srityje yra \u012fkvepiantis, ir mes d\u017eiaugiam\u0117s gal\u0117dami palaikyti j\u0173 kelion\u0119 kartu su KHP Ventures.<\/em>.<\/p>\n<\/div>\n<p><script>\n        !function(f,b,e,v,n,t,s)\n        {if(f.fbq)return;n=f.fbq=function(){n.callMethod?\n            n.callMethod.apply(n,arguments):n.queue.push(arguments)};\n            if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\n            n.queue=();t=b.createElement(e);t.async=!0;\n            t.src=v;s=b.getElementsByTagName(e)(0);\n            s.parentNode.insertBefore(t,s)}(window, document,'script',\n            'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\n        fbq('init', '154586475232058');\n        fbq('track', 'PageView');\n    <\/script><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.eu-startups.com\/2024\/12\/cambridge-based-52north-secures-e5-7-million-funding-to-advance-oncology-focused-innovations\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>52North, JK medicinos technologij\u0173 startuolis, orientuotas \u012f onkologini\u0173 lig\u0173 pa\u017eang\u0105, surinko 6 mln. EUR per finansavim\u0105, kuriam kartu vadovavo KHP Ventures ir Cedars-Sinai Intellectual Property Co. (CSIP). Turas, \u012f kur\u012f taip pat \u012fne\u0161\u0117 \u201eOKG Capital\u201c, \u201eCambridge Enterprise Ventures\u201c, \u201eCancer Research Horizons\u201c, \u201eMacmillan Cancer Support\u201c ir investuotojai angelai, tokie kaip Jonathanas Milneris ir Rolandas Diggelmannas, padidino&#8230;<\/p>\n","protected":false},"author":1,"featured_media":904,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[1931,53,1930,56,55],"class_list":["post-903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europos-verslo-naujienos","tag-52north","tag-isikurusi","tag-kembridze","tag-mln","tag-uzsitikrina"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/comments?post=903"}],"version-history":[{"count":0,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media\/904"}],"wp:attachment":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media?parent=903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/categories?post=903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/tags?post=903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}